While not significant, the IHC study is underpowered and could yield a significant trend if more samples were assessed.
← all excerpts
GMFG Has Potential to Be a Novel Prognostic Marker and Related to Immune Infiltrates in Breast Cancer.
1
—
—
While not significant, the IHC study is underpowered and could yield a significant trend if more samples were assessed.